Cardiovascular and cardiac fine structural effects of the nonequilibrium alpha-blocking agent, EEDQ.
D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology*; D000818:Animals; D002415:Cats; D002467:Cell Nucleus / Q000648:ultrastructure; D006003:Glycogen / Q000378:metabolism; D006321:Heart / Q000187:drug effects / Q000502:physiology*; D009200:Myocardial Contraction / Q000187:drug effects*; D009206:Myocardium / Q000378:metabolism / Q000648:ultrastructure*; D011804:Quinolines / Q000494:pharmacology*; D013329:Structure-Activity Relationship
D000317:Adrenergic alpha-Antagonists; D011804:Quinolines; D006003:Glycogen